Nanobiotix SA - ADRNBTX
13F holders, Q1 2025 (March 31)12holders −6
1new positions
7sold out
$3.58avg. 13F price*
At the end of Q1 2025, 12 institutions reported holding Nanobiotix SA - ADR (NBTX) in their 13F filings, down 6 from Q4 2024. 1 opened new positions and 7 sold out. The largest holders were Johnson & Johnson ($20.1M), Perceptive Advisors LLC ($376K) and Jane Street Group, LLC ($41K).
- Company
- Nanobiotix SA - ADR
- CUSIP
- 63009J107
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $2K |
| Exits | 7 | $380K |
All 13F filers, Q4 2024 → Q1 2025: 1,666 shares bought and 307,703 shares sold, net −306,037 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 12 holders
| Johnson & Johnson | 5.89% | No change | 5,623,816 | $20.1M |
| Perceptive Advisors LLC | 0.01% | Reduce -60.5% | 105,053 | $376K |
| Jane Street Group, LLC | 0.00% | Reduce -51.1% | 11,387 | $41K |
| Geode Capital Management, LLC | 0.00% | No change | 10,184 | $36K |
| Morgan Stanley | 0.00% | Add +19.6% | 6,100 | $22K |
| UBS Group AG | 0.00% | Reduce -21.4% | 3,000 | $11K |
| Bank of America Corp. | 0.00% | Reduce -70.8% | 706 | $3K |
| BNP Paribas Financial Markets | 0.00% | New | 661 | $2K |
| Citigroup Inc. | 0.00% | No change | 241 | $853 |
| Rhumbline Advisers | 0.00% | No change | 33 | $116 |
| Barclays PLC | 0.00% | No change | 4 | $14 |
| Royal Bank of Canada | 0.00% | Add +5.4% | 136 | $0 |
"% of holder's portfolio" is NBTX's weight in each manager's 13F, not the share of Nanobiotix SA - ADR the manager owns.